International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(8), С. 4522 - 4522
Опубликована: Апрель 20, 2024
Here,
we
target
the
high-density
lipoprotein
(HDL)
proteome
in
a
case
series
of
16
patients
with
post-COVID-19
symptoms
treated
HMG-Co-A
reductase
inhibitors
(statin)
plus
angiotensin
II
type
1
receptor
blockers
(ARBs)
for
6
weeks.
Patients
suffering
from
persistent
(post-acute
sequelae)
after
serologically
confirmed
SARS-CoV-2
infection
(post-COVID-19
syndrome,
PCS,
n
=
8)
or
following
vaccination
(PVS,
were
included.
Asymptomatic
subjects
corresponding
serological
findings
served
as
healthy
controls
(n
8/8).
HDL
was
isolated
using
dextran
sulfate
precipitation
and
all
study
participants
analyzed
quantitatively
by
mass
spectrometry.
Clinical
assessed
questionnaires
before
therapy.
The
inflammatory
potential
patients’
addressed
human
endothelial
cells.
PCS
PVS
showed
no
significant
differences;
however,
compared
to
controls,
PVS/PCS
displayed
alterations
involving
hemoglobin,
cytoskeletal
proteins
(MYL6,
TLN1,
PARVB,
TPM4,
FLNA),
amyloid
precursor
protein.
Gene
Ontology
Biological
Process
(GOBP)
enrichment
analysis
identified
hemostasis,
peptidase,
regulation
pathways
be
involved.
Treatment
statins
ARBs
improved
clinical
symptoms.
After
therapy,
three
significantly
increased
(FAM3C,
AT6AP2,
ADAM10;
FDR
<
0.05)
PVS/PCS.
Exposure
cells
revealed
reduced
cytokine
adhesion
molecule
expression.
Thus,
enables
deeper
insight
into
underlying
disease
mechanisms,
pointing
involvement
metabolic
signaling
disturbances.
proteome.
These
observations
may
guide
future
therapeutic
strategies
patients.
Pathology - Research and Practice,
Год журнала:
2023,
Номер
246, С. 154497 - 154497
Опубликована: Май 3, 2023
Worldwide
there
have
been
over
760
million
confirmed
coronavirus
disease
2019
(COVID-19)
cases,
and
13
billion
COVID-19
vaccine
doses
administered
as
of
April
2023,
according
to
the
World
Health
Organization.
An
infection
with
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
can
lead
an
disease,
i.e.
COVID-19,
but
also
a
post-acute
(PACS,
"long
COVID").
Currently,
side
effects
vaccines
are
increasingly
being
noted
studied.
Here,
we
summarise
currently
available
indications
discuss
our
conclusions
that
(i)
these
specific
similarities
differences
PACS,
(ii)
new
term
should
be
used
refer
(post-COVID-19
vaccination
syndrome,
PCVS,
colloquially
"post-COVIDvac-syndrome"),
(iii)
is
need
distinguish
between
(ACVS)
(PACVS)
-
in
analogy
PACS
("long
Moreover,
address
mixed
forms
caused
by
natural
SARS-CoV-2
vaccination.
We
explain
why
it
important
for
medical
diagnosis,
care
research
use
terms
(PCVS,
ACVS
PACVS)
order
avoid
confusion
misinterpretation
underlying
causes
enable
optimal
therapy.
do
not
recommend
"Post-Vac-Syndrome"
imprecise.
The
article
serves
current
problem
"medical
gaslighting"
relation
PCVS
raising
awareness
among
professionals
supplying
appropriate
terminology
disease.
Biomedicines,
Год журнала:
2023,
Номер
11(8), С. 2287 - 2287
Опубликована: Авг. 17, 2023
The
COVID-19
pandemic
caused
much
illness,
many
deaths,
and
profound
disruption
to
society.
production
of
‘safe
effective’
vaccines
was
a
key
public
health
target.
Sadly,
unprecedented
high
rates
adverse
events
have
overshadowed
the
benefits.
This
two-part
narrative
review
presents
evidence
for
widespread
harms
novel
product
mRNA
adenovectorDNA
is
in
attempting
provide
thorough
overview
arising
from
new
technology
that
relied
on
human
cells
producing
foreign
antigen
has
pathogenicity.
first
paper
explores
peer-reviewed
data
counter
attached
these
technologies.
Spike
protein
pathogenicity,
termed
‘spikeopathy’,
whether
SARS-CoV-2
virus
or
produced
by
vaccine
gene
codes,
akin
‘synthetic
virus’,
increasingly
understood
terms
molecular
biology
pathophysiology.
Pharmacokinetic
transfection
through
body
tissues
distant
injection
site
lipid-nanoparticles
viral-vector
carriers
means
‘spikeopathy’
can
affect
organs.
inflammatory
properties
nanoparticles
used
ferry
mRNA;
N1-methylpseudouridine
employed
prolong
synthetic
function;
biodistribution
DNA
codes
translated
spike
proteins,
autoimmunity
via
contribute
harmful
effects.
reviews
autoimmune,
cardiovascular,
neurological,
potential
oncological
effects,
autopsy
spikeopathy.
With
gene-based
therapeutic
technologies
planned,
re-evaluation
necessary
timely.
Science Immunology,
Год журнала:
2023,
Номер
8(83)
Опубликована: Май 5, 2023
Rare
immune-mediated
cardiac
tissue
inflammation
can
occur
after
vaccination,
including
SARS-CoV-2
mRNA
vaccines.
However,
the
underlying
immune
cellular
and
molecular
mechanisms
driving
this
pathology
remain
poorly
understood.
Here,
we
investigated
a
cohort
of
patients
who
developed
myocarditis
and/or
pericarditis
with
elevated
troponin,
B-type
natriuretic
peptide,
C-reactive
protein
levels
as
well
imaging
abnormalities
shortly
vaccination.
Contrary
to
early
hypotheses,
did
not
demonstrate
features
hypersensitivity
myocarditis,
nor
they
have
exaggerated
SARS-CoV-2-specific
or
neutralizing
antibody
responses
consistent
hyperimmune
humoral
mechanism.
We
additionally
found
no
evidence
cardiac-targeted
autoantibodies.
Instead,
unbiased
systematic
serum
profiling
revealed
elevations
in
circulating
interleukins
(IL-1β,
IL-1RA,
IL-15),
chemokines
(CCL4,
CXCL1,
CXCL10),
matrix
metalloproteases
(MMP1,
MMP8,
MMP9,
TIMP1).
Subsequent
deep
using
single-cell
RNA
repertoire
sequencing
peripheral
blood
mononuclear
cells
during
acute
disease
expansion
activated
CXCR3
Magnetocardiography
(MCG),
which
uses
high-sensitivity
magnetometers
to
record
magnetic
field
signals
generated
by
electrical
activity
in
the
heart,
is
a
noninvasive
method
for
evaluating
heart
diseases
such
as
arrhythmia
and
ischemia.
The
MCG
measurements
usually
require
participant
keeping
still
magnetically
shielded
room
due
immovable
sensor
noisy
external
environments.
These
requirements
limit
applications,
exercise
tests
long-term
observations,
are
useful
early
detections
of
diseases.
Here,
we
introduce
movable
system
that
can
clearly
freely
behaving
participants
an
unshielded
environment.
On
basis
optically
pumped
with
sensitivity
140
fT/Hz
1/2
,
successfully
demonstrated
resting
tests.
Our
promising
realize
practical
multichannel
nearly
sets
no
limits
brings
another
kind
insight
into
medical
diagnosis
disease.
ESC Heart Failure,
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 14, 2024
Abstract
COVID‐19
vaccines
have
been
linked
to
myocarditis,
which,
in
some
circumstances,
can
be
fatal.
This
systematic
review
aims
investigate
potential
causal
links
between
and
death
from
myocarditis
using
post‐mortem
analysis.
We
performed
a
of
all
published
autopsy
reports
involving
vaccination‐induced
through
3
July
2023.
All
studies
that
include
vaccine‐induced
as
possible
cause
were
included.
Causality
each
case
was
assessed
by
three
independent
physicians
with
cardiac
pathology
experience
expertise.
initially
identified
1691
and,
after
screening
for
our
inclusion
criteria,
included
14
papers
contained
28
cases.
The
cardiovascular
system
the
only
organ
affected
26
In
two
cases,
characterized
consequence
multisystem
inflammatory
syndrome.
mean
age
44.4
years
old.
median
number
days
last
vaccination
until
6.2
days,
respectively.
established
deaths
most
likely
causally
clinical
information
presented
paper.
temporal
relationship,
internal
external
consistency
seen
among
cases
this
known
its
pathobiological
mechanisms,
related
excess
death,
complemented
confirmation,
adjudication,
application
Bradford
Hill
criteria
overall
epidemiology
vaccine
suggests
there
is
high
likelihood
link
myocarditis.
Following
the
start
of
COVID-19
vaccination
campaign,
adverse
events
myocarditis
and
pericarditis
were
linked
mainly
to
mRNA
vaccines
by
regulatory
authorities
worldwide.
have
been
administered
several
million
people
risk
post
has
characterised
in
great
detail.
At
present
time
research
data
available
are
scarce
there
is
still
no
clear
understanding
biological
mechanism/s
responsible
for
this
disease.
This
manuscript
provides
a
concise
overview
epidemiology
most
prominent
mechanistic
insights
pathophysiology
Most
importantly
it
underscores
needed
next
steps
agenda
required
characterize
disease
post-COVID-19
vaccination.
Finally,
shares
our
perspectives
considerations
public
health.
Cell Communication and Signaling,
Год журнала:
2024,
Номер
22(1)
Опубликована: Янв. 15, 2024
Abstract
Background
Hyperinflammation,
hypercoagulation
and
endothelial
injury
are
major
findings
in
acute
post-COVID-19.
The
SARS-CoV-2
S
protein
has
been
detected
as
an
isolated
element
human
tissues
reservoirs
is
the
main
product
of
mRNA
COVID-19
vaccines.
We
investigated
whether
alone
triggers
pro-inflammatory
pro-coagulant
responses
primary
cultures
two
cell
types
deeply
affected
by
SARS-CoV-2,
such
monocytes
cells.
Methods
In
umbilical
vein
cells
(HUVEC)
monocytes,
components
NF-κB
NLRP3
inflammasome
system,
well
coagulation
regulators,
were
assessed
qRT-PCR,
Western
blot,
flow
cytometry,
or
indirect
immunofluorescence.
Results
activated
NF-κB,
promoted
cytokines
release,
triggered
priming
activation
system
resulting
mature
IL-1β
formation
both
types.
This
was
paralleled
enhanced
production
factors
von
Willebrand
factor
(vWF),
VIII
tissue
factor,
that
mediated,
at
least
part,
IL-1β.
Additionally,
failed
to
enhance
ADAMTS-13
levels
counteract
activity
vWF
multimers.
Monocytes
HUVEC
barely
expressed
angiotensin-converting
enzyme-2.
Pharmacological
approaches
gene
silencing
showed
TLR4
receptors
mediated
effects
but
not
HUVEC.
Conclusion
behaves
a
stimulus
Interfering
with
signaling
pathways
evoked
may
help
preventing
immune
vascular
complications
driven
viral
element.
European Cardiology Review,
Год журнала:
2023,
Номер
18
Опубликована: Июнь 7, 2023
Nuclear
factor
kappa-light-chain-enhancer
of
activated
B
cells
(NF-κB)
is
responsible
for
the
regulation
genes
involved
in
inflammation
and
immune
responses.
NF-κB
may
play
an
important
role
cardiovascular
diseases
(CVDs),
atherosclerosis
diabetes.
Several
therapeutic
agents
used
treatment
CVDs
diabetes,
such
as
pimobendan
sodium–glucose
cotransporter
2
inhibitors,
exert
anti-inflammatory
effects
by
inhibiting
activation;
therapy
have
beneficial
pharmacological
natural
compounds
inhibit
NF-κB,
these
alone
or
combination
be
to
treat
various
inflammatory
diseases.
Immunoglobulin-free
light
chains
could
surrogate
biomarkers
activation
useful
evaluating
efficacy
agents.
This
review
discusses
recent
advances
our
understanding
how
signalling
pathway
controls
inflammation,
metabolism
immunity,
improved
knowledge
pathways
lead
better
diagnostics
therapeutics
human
Biomedicines,
Год журнала:
2023,
Номер
11(2), С. 451 - 451
Опубликована: Фев. 3, 2023
The
SARS-CoV-2
(severe
acute
respiratory
syndrome
coronavirus
responsible
for
the
COVID-19
disease)
uses
Spike
proteins
of
its
envelope
infecting
target
cells
expressing
on
membrane
angiotensin
converting
enzyme
2
(ACE2)
that
acts
as
a
receptor.
To
control
pandemic,
genetically
engineered
vaccines
have
been
designed
inducing
neutralizing
antibodies
against
proteins.
These
do
not
act
like
traditional
protein-based
vaccines,
they
deliver
message
in
form
mRNA
or
DNA
to
host
then
produce
and
expose
protein
(from
which
it
can
be
shed
soluble
form)
alert
immune
system.
Mass
vaccination
has
brought
light
various
adverse
effects
associated
with
these
based
mainly
affecting
circulatory
cardiovascular
ACE2
is
present
membrane-bound
several
cell
types,
including
mucosa
upper
gastrointestinal
tracts,
endothelium,
platelets,
plasma.
converts
vasoconstrictor
II
into
peptides
vasodilator
properties.
Here
we
review
pathways
immunization
molecular
mechanisms
through
protein,
either
from
encoded
by
mRNA-based
interferes
Renin-Angiotensin-System
governed
ACE2,
thus
altering
homeostasis
circulation
Understanding
interactions
consequent
impact
system
will
direct
diagnosis
therapy
vaccine-related
provide
information
development
personalized
considers
pathophysiological
conditions
predisposing
such
events.